Immunetics develops and markets immunoassay and molecular probe technology solutions for the diagnosis of infectious diseases. The company offers diagnostic assays in ELISA and other immunoassay formats for the clinical laboratory. Its portfolio includes C6 B.burgdorferi (Lyme) ELISA KitQuick, ELISA Anthrax-PA Kit and BacTx Bacterial Detection Kit. The company also serves healthcare professionals worldwide. Immunetics was founded in 1987 and is based in Boston, Massachusetts.